Concepedia

Hui Li

HL

Statistics

Publications

4

Citations

87

H-Index

4

Active since

2016

Affiliations

Texas Children's Hospital(Current)

Baylor College of Medicine

Children's Cancer Center

Hui Li is an author at Texas Children's Hospital specializing in molecular oncology, pharmacology, and oncology.

Publications per year

2016–2025

4

Publications

4

Novel Src/Abl tyrosine kinase inhibitor bosutinib suppresses neuroblastoma growth via inhibiting Src/Abl signaling

Shayahati Bieerkehazhi, Zhenghu Chen, Yanling Zhao et al. · Oncotarget · 2016 · 39 citations · Full text

Medicine, Oncology, Pharmacology +12

Small molecule inhibitor agerafenib effectively suppresses neuroblastoma tumor growth in mouse models via inhibiting ERK MAPK signaling

Hui Li, Yang Yu, Yanling Zhao et al. · Cancer Letters · 2019 · 21 citations

Medicine, Oncology, Pharmacology +12

Anti-ganglioside GD2 monoclonal antibody synergizes with cisplatin to induce endoplasmic reticulum-associated apoptosis in osteosarcoma cells

Weihong Zhu, Xinzhan Mao, Wanchun Wang et al. · Die Pharmazie · 2018 · 17 citations · Full text

Medicine, Oncology, Pharmacology +17

Sustained ROS scavenging and pericellular oxygenation by lignin composites rescue HIF-1α and VEGF levels to improve diabetic wound neovascularization and healing

Jangwook P. Jung, Oluyinka O. Olutoye, Tanuj J. Prajati et al. · Acta Biomaterialia · 2025 · 10 citations · Full text

Engineering, Bioengineering, Biomedical Engineering +17

1–4 of 4